Skip to content
Stryker logo

Stryker

SYK

Stryker Corporation is a global leader in medical technology that develops, manufactures, and markets a diverse array of innovative healthcare solutions.

Market cap
$125.3B-17.1%
Revenue$25.3B+8.8%
Net income$3.3B+16.7%
Free cash flow$4.6B+27.8%
EPS (diluted)$8.64+16.8%
Trailing twelve months · change vs. prior year

Earnings

Next report

Jul 30, 2026 (In 2 weeks)
Revenue estimate$6.6B
EPS estimate$3.49

Financials

Q1 2026

Income statement

See full
Revenue$6.0B+2.6%
Gross profit$3.8B+1.8%
Operating income$936.0M+11.8%
Net income$745.0M+13.9%
EPS (diluted)$1.93+14.2%

Balance sheet

See full
Cash & equivalents$2.9B+24.1%
Total debt$14.4B-15.1%
Total assets$46.3B+0.6%

Cash flow

See full
Operating cash flow$581.0M+132%
CapEx$166.0M+35.0%
Free cash flow$415.0M+227%

Valuation & ratios

Valuation

See full
Market cap$125.3B-17.1%
Enterprise value$136.81B-17.3%
P/E37.6×-14.2×
P/S-1.4×

Profitability

See full
Gross margin63.8%-0.1pp
Operating margin19.7%+4.4pp
Net margin13.2%+0.9pp
FCF margin18.1%+2.7pp

Returns & leverage

See full
Current ratio2.1×+0.5×

Segments

By product

See full
Trauma and Extremities$1.0B+9.5%
Instruments$920.0M+9.8%
Medical$902.0M-4.6%
Endoscopy$868.0M+0.1%
Knees$670.0M+4.9%

By segment

See full
MedSurg and Neurotechnology:$3.2B+4.9%
Orthopaedics:$2.8B+0.1%

Competitors

Profile

Stryker Corporation is a global leader in medical technology that develops, manufactures, and markets a diverse array of innovative healthcare solutions. The company's core value proposition centers on improving patient and hospital outcomes through advanced surgical equipment, neurotechnology, and orthopaedic implants. Its mission is driven by a commitment to innovation, quality, and service across approximately 75 countries.

Competitive position

Stryker is a leading global competitor across all its primary product lines, maintaining a significant market share in orthopaedic robotics and surgical instrumentation.

GeographiesUnited States, Canada, Japan, South Korea, Europe, New Zealand
Customer segmentsHospitals, Specialized Surgeons, Healthcare Facilities, Emergency Responders
Business modelManufacturing, Direct-to-hospital sales, Software-as-a-Service (SaaS), Capital equipment sales
SuppliersRaw material suppliers, Single-source component manufacturers, Specialized sterilization service providers
CustomersHospitals, Healthcare facilities, Third-party dealers, Medical distributors
Listed1979
Employees52.0K
CEOKevin A. Lobo
FilingsSEC EDGAR

Questions, answered.

What is Stryker's market cap?
Stryker (SYK) has a market capitalization of $125.30B and trades on NYSE.
What is Stryker's revenue and profitability?
Stryker generated $25.3B in trailing twelve-month revenue with net income of $3.3B, representing a net margin of 13.2%. Gross margin stands at 63.8%, with free cash flow of $4.6B. These figures are based on the Q1 2026 filing.
Who are Stryker's competitors?
Stryker's key competitors include CONMED Corporation, Medtronic plc, Johnson & Johnson MedTech, and others. These companies compete in similar markets and product categories.
Who does Stryker partner with?
Stryker's notable partners include Arthrex, Inc..
What subsidiaries does Stryker have?
Stryker's subsidiaries include Vertos Medical, Inc., care.ai, SERF SAS, and others.
Where is Stryker headquartered?
Stryker is headquartered in United States of America and employs approximately 52,000 people. It has been publicly traded since 1979.